Optina raises $2.1m from ADDF’s diagnostics accelerator

Montreal-based diagnostics company Optina has secured $2.1 million in funding from the diagnostics accelerator at the Alzheimer's Drug Discovery Foundation.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this